It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing Found
- Weekly Market Review – April 20, 2024
- Alto Neuroscience preps IPO to push precision psychiatry therapies through the clinic
- Machine learning hunt finds hundreds of new cancer targets, many with biomarkers to boot
- ResMed’s warning on CPAP magnet interference earns FDA Class I recall tag
- Illumina Ventures launches refreshed genomics startup accelerator program
- LegoChem, riding ADC sugar rush, raises $411M from confectionery company
- Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount
- AbbVie-backed Disco gets down with €20M to find new targets for antibody-based therapies
- Roche’s pharma BD chief explains renewed ADC interest but is spoilt for choice
- The Number of Americans Applying for Jobless Benefits Holds Steady as Labor Market Remains Strong